Title
Aldehyde Dehydrogenase (ALDH) 2 in Diabetic Heart Diseases
Recommended Citation
Munukutla S, Pan G, Palaniyandi SS. Aldehyde Dehydrogenase (ALDH) 2 in Diabetic Heart Diseases. Advances in experimental medicine and biology 2019; 1193:155-174.
Document Type
Book
Publication Date
1-1-2019
Publication Title
Advances in experimental medicine and biology
Abstract
A major pathophysiological mechanism behind the development of diabetic heart diseases is oxidative stress mediated by toxic reactive aldehydes such as 4-hydroxynonenal (4HNE). Aldehyde dehydrogenase (ALDH) 2 is a mitochondrial enzyme that has been found to detoxify these deleterious aldehydes and thereby mitigate cardiac damage. Furthermore, its protective role in cellular signaling reverses aberrations caused by hyperglycemia, thereby protecting cardiac function. This chapter assesses the role of ALDH2 in diabetic heart diseases by examining preclinical studies where ALDH2 activity is perturbed in both decreased and increased directions. In doing so, issues in improving ALDH2 activity in select human populations are elucidated, and further research directions are discussed.
Medical Subject Headings
Aldehyde Dehydrogenase, Mitochondrial; Aldehydes; Diabetes Mellitus; Heart Diseases; Humans; Oxidative Stress
PubMed ID
31368103
Volume
1193
First Page
155
Last Page
174
